These results might partly explain why diabetes mellitus (DM) leads to poorer outcome in stroke patients (Lau et al., 2019), as an inadequate level of GLUT1 exacerbates BBB damage, and provide insights into the neuroprotection of stroke patients with DM. This evidence concerns the gene SLC2A1 and diabetes mellitus.